BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1380867)

  • 1. Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset.
    Pérez-Otaño I; Herrero MT; Luquin MR; Obeso JA; Del Río J
    Brain Res; 1992 Jul; 585(1-2):156-60. PubMed ID: 1380867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
    Taylor MD; de Ceballos ML; Rose S; Chong PN; Jenner P; Marsden CD
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):99-108. PubMed ID: 1716907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
    Jenner P; Taquet H; Mauborgne A; Benoliel JT; Cesselin F; Rose S; Javoy-Agid F; Agid Y; Marsden CD
    J Neurochem; 1986 Nov; 47(5):1548-51. PubMed ID: 2428937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
    Jolkkonen J; Jenner P; Marsden CD
    Brain Res Mol Brain Res; 1995 Sep; 32(2):297-307. PubMed ID: 7500841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms.
    Dacko S; Schneider JS
    Neurosci Lett; 1991 Jun; 127(1):49-52. PubMed ID: 1881617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
    Taquet H; Nomoto M; Rose S; Jenner P; Javoy-Agid F; Mauborgne A; Benoliel JJ; Marsden CD; Legrand JC; Agid Y
    Neuropeptides; 1988 Oct; 12(3):105-10. PubMed ID: 2468106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical analysis.
    Roeling TA; Docter GJ; Voorn P; Melchers BP; Wolters EC; Groenewegen HJ
    J Chem Neuroanat; 1995 Oct; 9(3):155-64. PubMed ID: 8588831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G; Jenner P
    Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets.
    Ando K; Maeda J; Inaji M; Okauchi T; Obayashi S; Higuchi M; Suhara T; Tanioka Y
    Psychopharmacology (Berl); 2008 Jan; 195(4):509-16. PubMed ID: 17879087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain.
    Pérez-Otaño I; Luquin MR; Oset C; Herrero MT; Kupsch A; Oertel W; Obeso JA; Del Río J
    Exp Neurol; 1995 Jan; 131(1):108-13. PubMed ID: 7534717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH
    Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin.
    Gerlach M; Götz M; Dirr A; Kupsch A; Janetzky B; Oertel W; Sautter J; Schwarz J; Reichmann H; Riederer P
    Neurochem Int; 1996 Jan; 28(1):41-9. PubMed ID: 8746763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and L-DOPA treatment.
    Hurley MJ; Jolkkonen J; Stubbs CM; Jenner P; Marsden CD
    Brain Res; 1996 Feb; 709(2):259-64. PubMed ID: 8833762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.
    Rose S; Nomoto M; Jackson EA; Gibb WR; Jenner P; Marsden CD
    Eur J Pharmacol; 1990 May; 181(1-2):97-103. PubMed ID: 2117541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
    Riahi G; Morissette M; Samadi P; Parent M; Di Paolo T
    Biochem Pharmacol; 2013 Oct; 86(7):970-8. PubMed ID: 23954709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1990 May; 70(5):252-4, 18. PubMed ID: 2168792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?
    Allen JM; Cross AJ; Yeats JC; Ghatei MA; McGregor GP; Close SP; Pay S; Marriott AS; Tyers MB; Crow TJ
    Brain; 1986 Feb; 109 ( Pt 1)():143-57. PubMed ID: 2417654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.